|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500096997 |
|
最近更新日期: Date of Last Refreshed on: |
2025-02-10 18:11:21 |
|
注册时间: Date of Registration: |
2025-02-10 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
不同参数的加速间歇性θ波爆发磁刺激治疗青少年抑郁症的疗效观察 |
|
Public title: |
Effect of accelerated intermittent theta burst magnetic stimulation with different parameters on adolescent depression |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
不同参数的加速间歇性θ波爆发磁刺激治疗青少年抑郁症的疗效观察 |
|
Scientific title: |
Effect of accelerated intermittent theta burst magnetic stimulation with different parameters on adolescent depression |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
范宏艳 |
研究负责人: |
郑蕾 |
|
Applicant: |
Fan Hongyan |
Study leader: |
Zheng Lei |
|
申请注册联系人电话: Applicant telephone: |
+86 178 6575 3115 |
研究负责人电话:
Study leader's |
+86 183 0258 2420 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
3130475915@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
1173765117@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
贵州省贵阳市云岩区普陀路92号 |
研究负责人通讯地址: |
贵州省贵阳市云岩区贵医街28号 |
|
Applicant address: |
92 Putuo Road, Yunyan District, Guiyang City, Guizhou Province |
Study leader's address: |
28 Guiyi Street, Yunyan District, Guiyang City, Guizhou Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
贵州医科大学 |
||
|
Applicant's institution: |
Guizhou Medical University |
||
|
研究负责人所在单位: |
贵州医科大学附属医院 |
||
|
Affiliation of the Leader: |
Affiliated Hospital of Guizhou Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2024伦审第(211)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
贵州医科大学附属医院医学科学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Science Ethics Committee of Affiliated Hospital of Guizhou Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-06-11 00:00:00 | ||
|
伦理委员会联系人: |
楚兰 |
||
|
Contact Name of the ethic committee: |
Chu Lan |
||
|
伦理委员会联系地址: |
贵州省贵阳市云岩区贵医街28号 |
||
|
Contact Address of the ethic committee: |
28 Guiyi Street, Yunyan District, Guiyang City, Guizhou Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 851 8681 4581 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
贵州医科大学附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Guizhou Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
贵州省贵阳市云岩区贵医街28号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
28 Guiyi Street, Yunyan District, Guiyang City, Guizhou Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
无 |
||||||||||||||||||||||
|
Source(s) of funding: |
None |
||||||||||||||||||||||
|
研究疾病: |
抑郁发作 |
||||||||||||||||||||||
|
Target disease: |
Depressive episode |
||||||||||||||||||||||
|
研究疾病代码: |
F32.900 |
||||||||||||||||||||||
|
Target disease code: |
F32.900 |
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
II期临床试验 | ||||||||||||||||||||||
|
Study phase: |
2 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
探索不同参数的加速间歇性θ波爆发磁刺激治疗青少年抑郁症的反应率及脑功能变化 |
||||||||||||||||||||||
|
Objectives of Study: |
To explore the response rate and brain function changes of different parameters of accelerated intermittent theta burst magnetic stimulation in the treatment of adolescent depression |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①符合DSM-5重度抑郁障碍诊断标准;②右利手,脑电图正常;③年龄12~19岁;④蒙哥马利-艾森贝格抑郁量表(MADRS)≥22分;⑤患者于治疗期间采取单一选择性5-羟色胺再摄取抑制剂;⑥患者和监护人均知情同意并签署知情同意书;⑦获得伦理委员会审核批准。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) Meet the DSM-5 diagnostic criteria for major depressive disorder; (2) Right-handed, EEG normal; (3) Age 12-19 years old; (4) Montgomery-Eisenberg Depression Scale (MADRS) ≥22 points; (5) Patients took a single selective serotonin reuptake inhibitor during treatment; (6) Informed consent and signed informed consent by both patient and guardian; ⑦ Get the approval of the Ethics committee. |
||||||||||||||||||||||
|
排除标准: |
①怀疑或己确诊为精神分裂症谱系及其他精神病性障碍、双相障碍、精神活性物质使用史;②有脑部手术史;③有癫痫史和家族史;④严重头痛、高血压、恶性肿瘤、开放性伤口、血管栓塞、白细胞减少、传染性疾病等患者;⑤身体内置有金属或电子仪器者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1 Suspected or confirmed schizophrenia spectrum and other psychiatric disorders, bipolar disorder, psychoactive substance use history; 2 Have a history of brain surgery; 3 A history of epilepsy and family history; 4 Patients with severe headache, hypertension, malignant tumor, open wound, vascular embolism, leukopenia, infectious diseases, etc.; 5 Those who have metal or electronic devices built into their bodies. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-02-16 00:00:00至 To 2027-07-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-02-16 00:00:00 至 To 2027-07-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由范宏艳通过SPSS27设置随机数字表,由此随机分配 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The random number table is set by Fan Hongyan through SPSS27, and then randomly allocated |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2035年6月30日通过邮箱(fhy335887@163.com)共享数据。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Data was shared via email (fhy335887@163.com) on 30 June 2035 |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
本试验是CRF表、EDC系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
This test is CRF table, EDC system |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |